Diabetes Pro Quarterly - Summer 2020 - 16

Research News

2020 National Scientific & Health Care Achievement
Award Recipients Honored
Presented to recognize and honor individuals in the diabetes scientific and medical community, the American Diabetes Association's
(ADA's) National Scientific & Health Care Achievement Awards are bestowed on individuals who have demonstrated exceptional
leadership in their fields. Specifically, these awards honor individuals who have made significant contributions through their
outstanding career achievements and support in the areas of diabetes research, clinical care, and education, including training,
mentoring, and international impact. A recording of the 2020 Awards Ceremony can be viewed at https://uat-journals.lww.com/
ada2020demo/Pages/awards.aspx.

Banting Medal for Scientific Achievement
Ele Ferrannini, MD
A senior research associate at the National
Research Council Institute of Clinical Physiology
and professor of medicine at the University of
Pisa, Dr. Ferrannini is renowned for his contributions to the
fields of insulin resistance and associated disorders (hypertension,
dyslipidemia), ß-cell function and dysfunction in vivo, the
incretin effect, and the cardiovascular complications of diabetes.
Dr. Ferrannini has also done pioneering work in therapeutics,
including DPP-4 and SGLT2 inhibition and bariatric surgery.
Dr. Ferrannini's research initially delved into the phenotyping
of human insulin resistance, including sites, degree, and
mechanisms. With his longtime associate Dr. Andrea Mari,
he next developed a physiologically based mathematical model
of β-cell function using the dominant role of β-cell glucose
sensitivity in the prediction, development, and treatment of
β-cell dysfunction in both type 2 and type 1 diabetes. His
ultimate vision is to explain diabetes as the result of integrated
multi-organ responses that contribute to hyperglycemia and the
risk of both macro- and microvascular complications.
Dr. Ferrannini's illustrious contributions have been recognized by
prestigious honors, including the Claude Bernard Award of the
European Association for the Study of Diabetes and honorary
doctorates from the Universities of Turku (Finland) and the
University of Patras (Greece). He has collaborated with countless
eminent colleagues around the world and mentored many scientists.

Outstanding Scientific Achievement Award
Jiandie Lin, PhD
Dr. Lin received his Bachelor of Science in
biochemistry from Peking University (1994)
and his doctorate in biochemistry and molecular
biology and cell biology from Northwestern University (2000).
His postdoctoral work with Dr. Bruce Spiegelman revealed
insights into the role of the PGC-1 transcriptional coactivators
in mitochondrial oxidative metabolism and metabolic
physiology. In 2005, Dr. Lin started his independent research
16

DiabetesPro Quarterly | SUMMER 2020

career in the Department of Cell & Developmental Biology
and Life Sciences Institute at the University of Michigan.
Dr. Lin's research interfaces the basic biology of metabolic
signaling, pathophysiology of metabolic disease, and therapeutic
development. His lab explored the mechanisms through which
chromatin regulators link nutritional signaling to metabolic gene
programs. Dr. Lin's group pioneered the discovery of several
emerging endocrine factors and single-cell mapping of metabolic
tissue microenvironment in health and disease.
Dr. Lin has received an ADA Career Development Award,
Bradley M. Patten Collegiate Professorship, and Dean's Basic
Science Award at the University of Michigan Medical School.
He was elected a fellow of the American Association for the
Advancement of Science in 2018. He has been an active member
of the diabetes research community and currently serves as an
associate editor of Diabetes.

Outstanding Achievement in Clinical Diabetes
Research Award
Bernard Zinman, OC, MDCM, FRCPC,
FACP
Dr. Zinman is professor of medicine at the
University of Toronto and the Stephen and Suzie
Pustil Diabetes Research Scientist at the Lunenfeld-Tanenbaum
Research Institute, Mount Sinai Hospital, Toronto, Canada. His
main research interests include the long-term complications of
diabetes, the evaluation of new therapies for type 1 and type 2
diabetes, and diabetes in Aboriginal communities.
Dr. Zinman is the recipient of numerous awards, including the
Charles H. Best Medal for Distinguished Service in the Cause of
Diabetes and the Frederick G. Banting Award of the Canadian
Diabetes Association (CDA). In 2006, he received the ADA's
Outstanding Physician Clinician Award, and in 2009 he was
awarded the Lifetime Achievement Award from the CDA and
the Novartis Prize in Diabetes. In November 2011, Dr. Zinman
was appointed to the Order of Canada in recognition of his
achievements in diabetes patient care and research. In 2019, he
was promoted to officer in the Order of Canada. He has authored
more than 550 publications in national and international journals.

continued on next page

https://uat-journals.lww.com/ada2020demo/Pages/awards.aspx https://uat-journals.lww.com/ada2020demo/Pages/awards.aspx

Diabetes Pro Quarterly - Summer 2020

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Summer 2020